ATE377428T1 - Rotavirus-impfstoff - Google Patents

Rotavirus-impfstoff

Info

Publication number
ATE377428T1
ATE377428T1 AT97944477T AT97944477T ATE377428T1 AT E377428 T1 ATE377428 T1 AT E377428T1 AT 97944477 T AT97944477 T AT 97944477T AT 97944477 T AT97944477 T AT 97944477T AT E377428 T1 ATE377428 T1 AT E377428T1
Authority
AT
Austria
Prior art keywords
rotavirus vaccine
rotavirus
vaccine
vaccines
preparation
Prior art date
Application number
AT97944477T
Other languages
German (de)
English (en)
Inventor
Carl Burke
David Volkin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9621991.0A external-priority patent/GB9621991D0/en
Priority claimed from GBGB9714333.3A external-priority patent/GB9714333D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE377428T1 publication Critical patent/ATE377428T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT97944477T 1996-09-26 1997-09-26 Rotavirus-impfstoff ATE377428T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2675496P 1996-09-26 1996-09-26
GBGB9621991.0A GB9621991D0 (en) 1996-10-22 1996-10-22 Rotavirus vaccine formulations
US4676097P 1997-05-16 1997-05-16
GBGB9714333.3A GB9714333D0 (en) 1997-07-07 1997-07-07 Rotavirus vaccine formulations

Publications (1)

Publication Number Publication Date
ATE377428T1 true ATE377428T1 (de) 2007-11-15

Family

ID=27451542

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97944477T ATE377428T1 (de) 1996-09-26 1997-09-26 Rotavirus-impfstoff

Country Status (10)

Country Link
EP (2) EP0939648B1 (es)
JP (1) JP4653262B2 (es)
AT (1) ATE377428T1 (es)
AU (1) AU739916B2 (es)
CA (1) CA2266486C (es)
DE (1) DE69738271T2 (es)
DK (1) DK0939648T3 (es)
ES (1) ES2294801T3 (es)
PT (1) PT939648E (es)
WO (1) WO1998013065A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403098B1 (en) * 1996-09-26 2002-06-11 Merck & Co., Inc. Rotavirus vaccine formulations
DE60040727D1 (de) * 1999-02-05 2008-12-18 Merck & Co Inc Menschliche papillomavirus impfstoff-formulierungen
FR2791895B1 (fr) * 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
US6436993B1 (en) 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes
DE60028390T2 (de) * 1999-08-17 2006-11-02 Glaxosmithkline Biologicals S.A. Methoden um rotavirusvarianten zu trennen und lebender attenuierter rotavirus impfstoff
GB0503337D0 (en) 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
AU2013224715B2 (en) * 2007-03-22 2015-10-08 The Regents Of The University Of Colorado Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
CA2681567C (en) * 2007-03-22 2016-07-19 The Regents Of The University Of Colorado, A Body Corporate Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
AU2011336413B2 (en) 2010-12-02 2015-01-22 Oncolytics Biotech Inc. Liquid viral formulations
MX349294B (es) 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
US20130309273A1 (en) 2012-05-17 2013-11-21 Kimberly Hassett Thermostable Vaccine Compositions and Methods of Preparing Same
US12447127B2 (en) 2011-05-17 2025-10-21 The Regents Of The University Of Colorado, A Body Corporate Thermostable vaccine compositions and methods of preparing the same
US20140127260A1 (en) 2011-06-24 2014-05-08 Ramesh V. Chintala Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
US20140356396A1 (en) * 2011-08-25 2014-12-04 Brian L. Pulliam Rotavirus preparations with excess calcium ions and high viscosities that ensure viability at elevated temperatures
WO2013133702A1 (en) * 2012-03-05 2013-09-12 De Staat Der Nederlanden, Vert. Door De Minister Van Vws Methods and compositions for stabilizing dried biological materials
KR20170028992A (ko) * 2014-07-18 2017-03-14 엠에스디 웰컴 트러스트 힐레맨 랩스 피브이티. 리미티드 열안정성 동결 건조된 로타바이러스 백신 제형 및 이의 제조 방법
CN108367164A (zh) 2015-12-18 2018-08-03 默沙东公司 热稳定的轮状病毒疫苗制剂及其使用方法
MA44557B1 (fr) 2016-06-16 2021-11-30 Bharat Biotech Int Ltd Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer
IL290458B2 (en) * 2019-08-09 2025-06-01 Valneva Se Chikungunya vaccine formulations
WO2021028407A1 (en) * 2019-08-09 2021-02-18 Valneva Se Single shot chikungunya virus vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
CA2065847C (en) * 1990-07-26 2002-02-12 Stanley A. Plotkin Rotavirus reassortant vaccine
US7150984B2 (en) * 1994-07-11 2006-12-19 The United States Of America As Represented By The Department Of Health And Human Services Attenuated human rotavirus vaccine

Also Published As

Publication number Publication date
EP1891968A2 (en) 2008-02-27
WO1998013065A1 (en) 1998-04-02
ES2294801T3 (es) 2008-04-01
EP0939648A1 (en) 1999-09-08
EP0939648B1 (en) 2007-11-07
DE69738271D1 (de) 2007-12-20
JP2002500622A (ja) 2002-01-08
EP1891968A3 (en) 2008-09-03
AU739916B2 (en) 2001-10-25
CA2266486C (en) 2007-09-25
AU4596397A (en) 1998-04-17
DK0939648T3 (da) 2008-02-11
DE69738271T2 (de) 2008-08-28
CA2266486A1 (en) 1998-04-02
PT939648E (pt) 2008-01-11
JP4653262B2 (ja) 2011-03-16

Similar Documents

Publication Publication Date Title
DK0939648T3 (da) Rotavirusvaccineformuleringer
DK1021547T3 (da) Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf
FI931169A7 (fi) Parannetut rokotekoostumukset
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
PT758248E (pt) Formulacoes para o factor ix
HU9904549A (en) Vaccines
DE69943359D1 (de) Tumorassoziierte Antigenderivate der Mage-Familie, zur Herstellung von Fusionsproteinen mit T-Helper Epitope und Zusammensetzungen zur Impfung
NO910766L (no) Fremgangsmaate for fremstilling av titandioksyd.
IT8920207A0 (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
ES2089316T3 (es) Agente viral asociado con la enfermedad porcina misteriosa (mystery swine desease).
DK0745387T3 (da) Adjuvanser til virale vacciner
DK1047446T3 (da) Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf
DZ2283A1 (fr) Composition de vaccin.
PT792165E (pt) Composicoes imunogenicas
NO911065L (no) Fremgangsmaate for fremstilling av lipopeptidderivater.
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
DE69738641D1 (de) Lebend-impfstoff gegen heliobacter pylori
FI925032A7 (fi) Rokotekoostumukset
PT894500E (pt) Vacina para streptococcus equi
DK0493575T3 (da) Vaccine af reassortant rotavirus
DE69830156D1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
MX9202293A (es) Composicion de vacuna no-irritante.
EP0563288A4 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
GB9621991D0 (en) Rotavirus vaccine formulations
ZA978586B (en) Rotavirus vaccine formulations.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0939648

Country of ref document: EP

EEFA Change of the company name